VILDISHAL

This brand name is authorized in Nigeria.

Active ingredients

The drug VILDISHAL contains one active pharmaceutical ingredient (API):

1	Vildagliptin UNII I6B4B2U96P - VILDAGLIPTIN
	Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).
	Read more about Vildagliptin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100689	Tablet	VILDISHAL 50 TABLETS TAB 50 mg 3x10 tablets	35 NF-PP-369185 VILDISHAL 50 TABLETS Vildagliptin Tablets 50mg Vildagliptin Tablets 50mg (Excipients: Lactose Anhydrous BP, Microcrystalline Cellulose PH 102 BP, Sodium Starch Glycolate BP (Priimogel) and Magnesium Stearate BP) A4-100689 Drugs Imported Products 3x10Tablets POM 1 10/13/2023 SHALINA HEALTHCARE NIGERIA LIMITED, 19 Fatai Atere Way, Matori, Mushin 18183973 theophilus.adimoha@shalina.com EAST AFRICAN (INDIA) OVERSEAS, Plot No 1, Pharmacity Selaqui, Dehradun - 248011, Uttarakhand, India, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BH02	Vildagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100689